Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)α agonist and unaffected by an ERβ antagonist

Journal of Endocrinology

Volumn 197, Issue 3, 2008, Pages 493-501

  Jeanes, Helen L ^a   Tabor, Caroline ^a   Black, Darcey ^b   Ederveen, Antwan ^c   Gray, Gillian A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MERCK RESEARCH LABORATORIES   (United States)

^c NV Organon ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA STIMULATING AGENT; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA BLOCKING AGENT; HORMONE RECEPTOR AFFECTING AGENT; MYELOPEROXIDASE; PLACEBO;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CHO CELL; CONTROLLED STUDY; DRUG IMPLANTATION; DRUG PELLET; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; FEMALE; GENETIC TRANSFECTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; TRANSACTIVATION;

ANIMALS; BLOOD PRESSURE; CHO CELLS; CRICETINAE; CRICETULUS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; FREE RADICALS; MYOCARDIAL REPERFUSION INJURY; NEUTROPHIL INFILTRATION; RATS; RATS, WISTAR; TRANSCRIPTIONAL ACTIVATION;

EID: 44949140427     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0071     Document Type: Article

References (44)

1. Booth EA, Marchesi M, Kilbourne EJ & Lucchesi BR 2003 17Beta-estradiol as a receptor-mediated cardioprotective agent. Journal of Pharmacology and Experimental Therapeutics 307 395-401.
2. Booth EA, Obeid NR & Lucchesi BR 2005 Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. American Journal of Physiology. Heart and Circulatory Physiology 289 H2039-H2047.
3. Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardo FV, Mann GE & Vina J 2005 17Beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell 4 113-118.
4. Delyand JA, Murohara T, Nossuli TO & Lefer AM 1996 Protection from myocardial reperfusion injury by acute administration of 17 beta-estradiol. Journal of Molecular and Cellular Cardiology 28 1001-1008.
5. Dubey RK, Jackson EK, Keller PJ, Imthurn B & Rosselli M 2001 Estradiol metabolites inhibit enclothelin synthesis by an estrogen receptor-independent mechanism. Hypertension 37 640-644.
6. Frasor J, Barnett DH, Danes JM, Hess R, Parlow AF & Katzenellenbogen BS 2003 Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology 144 3159-3166.
7. Gabel SA, Walker VR, London RE, Steenbergen C, Korach KS & Murphy E 2005 Estrogen receptor beta mediates gender differences in ischemia/ reperfusion injury. Journal of Molecular and Cellular Cardiology 38 289-297.
8. de Gooyer ME, Deckers GH, Schoonen WG, Verheul HA & Kloosterboer HJ 2003 Receptor profiling and endocrine interactions of tibolone. Steroids 68 21-30.
9. Gray GA, Sharif I, Webb DJ & Seckl JR 2001 Oestrogen and the cardiovascular system: the good, the bad and the puzzling. Trends in Pharmacological Sciences 22 152-156.
10. Grohe C, Kahlert S, Lobbert K, Stimpel M, Karas RH, Vetter H & Neyses L 1997 Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Letters 416 107-112.
11. Grohe C, Kahlert S, Lobbert K & Vetter H 1998 Expression of oestrogen receptor alpha and beta in rat heart: role oflocal oestrogen synthesis. Journal of Endocrinology 156 R1-R7.
12. Hale SL, Birnbaum Y & Kloner RA 1996 beta-Estradiol, but not alpha-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. American Heart Journal 132 258-262.
13. Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, Hidaka H & Iguchi A 1995 Estrogen increases endoLhelial nitric oxide by a receptor-mediated system. Biochemical and Biophysical Research Communications 214 847-855.
14. Jankowski M, Rachelska G, Donghao W, McCann SM & Gutkowska J 2001 Estrogen receptors activate atrial narriuretic pepticle in the rat heart. PNAS 98 11765-11770.
15. Jeanes HL, Wanikiat P, Sharif I & Gray GA 2006 Medroxyprogesterone acetate inhibits the cardioprotective effect of estrogen in experimental ischemia-reperfusion injury. Menopause 13 80-86.
16. Jeanes H, Newby D & Gray GA 2007 Cardiovascular risk in women: the impact of hormone replacement therapy and prospects for new therapeutic approaches. Expert Opinion on Pharmacotherapy 8 279-288.
17. Kim YD, Farhat MY, Myers AK, Kouretas F, DeGroot KW, Pacquing A, Ramwell PW, Suyderhoud JP & Lees DE 1998 17-Beta estradiol regulation of myocardial glutathione and its role in protection against myocardial stunning in dogs. Journal qf Cardiovascular Pharmacology 32 457-465.
18. Kim JK, Pedram A, Razanch M & Levin ER 2006 Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms. Journal of Biological Chemistry 281 6760-6767.
19. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J & Hoppel CL 2001 Mitochondrial dysfunction in cardiac disease: ischerma-reperfusion, aging, and heart failure. Journal of Molecular and Cellular Cardiology 33 1065-1089.
20. McCord JM 1985 Oxygen-derived free radicals in postischernic tissue injury. New England Journal of Medicine 312 159-163.
21. McHugh NA, Merrill GF & Powell SR 1998 Estrogen diminishes postischemic hydroxyl radical production. American Journal of Physiology 274 H1950-H1954.
22. Mendelsohn ME & Karas RH 2005 Molecular and cellular basis of cardiovascular gender differences. Science 308 1583-1587.
23. Nikolic I, Liu D, Bell JA, Collins J, Steenbergen C & Murphy E. 2007 Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. Journal of Molecular and Cellular Cardiology 42 769-780.
24. Patten RD & Karas RH 2006 Estrogen replacement and cardiomyocyte protection. Trends in Cardiovascular Medicine 16 69-75.
25. Patten RD, Pouran I, Aronovitz MJ, Baur J, Celestin F, Chen X, Michael A, Haq S, Nuedhng S, Grohe C et al. 2004 17Beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phosphoinositide-3 kinase/Akt signaling. Circulation Research 95 692-699
26. Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, Bellotti V, Hawkins PN, Myers RM, Smith MD, Polara A et al. 2006 Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440 1217-1221.
27. Reimer KA, Murry CE & Richard VJ 1989 The role of neutrophils and free radicals in the ischemic-reperfused heart: why the confusion and controversy? Journal of Molecular and Cellular Cardiology 21 1225-1239.
28. Roesch DM 2006 Effects of selective estrogen receptor agonists on food intake and body weight gain in rats. Physiology and Behavior 87 39-44.
29. Schrepfer S, Deuse T, Munzel T, Schafer H, Braendle W & Reichenspurner H 2006 The selective estrogen receptor-beta agorust biochanin A shows vasculoprotective effects without uterotrophic activity. Menopause 13 489-499.
30. Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Arcoraci V, Minutoli L, Serrano M, Saitta A & Caputt AP 1997 17Beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat. European Journal of Pharmacology 335 185-192.
31. Stirone C, Duckles SP, Krause DN & Procaccio V 2005 Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Molecular Pharmacology 68 959-965.
32. Stumpf WE, Sar M & Aumuller G 1977 The heart: a target organ for estradiol. Science 196 319-321.
33. Stygar D, Westlund P, Eriksson H & Sahlin L 2006 Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mono-nuclear leucocytes. Clinical Endocrinology 64 74-81.
34. Tan E, Gujar MV, Sharma RV & Bhalla RC 1999 Estrogen receptor-alpha gene transfer into bovine aortic endothchal cells induces eNOS gene expression and inhibits cell migration. Cardiovascular Research 43 788-797.
35. Tauber AI & Babior BM 1977 Evidence for hydroxyl radical production by human neutrophils. Journal of Clinical Investigation 60 374-379.
36. Taylor AH, Fox-Robichaud AE, Egan C, Dionne J, Lawless DE, Raymond J, Romney J & Wong NC 2000 Oestrachol decreases rat apolipoprotein Al transcription via promoter site B. Journal of Molecular Endocrinology 25 207-219.
37. Urata Y, Ihara Y, Murata H, Goto S, Koji T, Yodoi J, Inoue S & Kondo T 2006 17Beta-estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. Journal of Biological Chemistry 281 13092-13102.
38. Wang M, Crisostomo P, Wairiuko GM & Meldrun DR 2006 Estrogen receptor-alpha mediates acute myocardial protection in females. American Journal of Physiology. Heart and Circulatory Physiology 290 H2204-H2209.
39. Yang SH, Liu R, Perez EJ, Wen Y, Stevens SM Jr, Valencia T, Brun-Zinkernagel AM, Prokai L, Will Y, Dykens J et al. 2004 Mitochondrial localization of estrogen receptor beta. PNAS 101 4130-4135.
40. Yu HP, Shimizu T, Choudhry MA, Hsieh YC, Suzuki T, Bland KI & Chaudry IH 2006 Mechanism of cardioprotection following trauma-hemorrhagic shock by a selective estrogen receptor-beca agonist: up-regulation of cardiac heat shock factor-1 and heat shock proteins. Journal of Molecular and Cellular Cardiology 40 185-194.
41. Zhai P, Eurell TE, Cooke PS, Lubahn DB & Gross DR 2000a Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice. American Journal of Physiology. Heart and Circulatory Physiology 278 H1640-H1647.
42. Zhai F, Eurell TE, Cotthaus R, Jeffery ELL Bahr JM & Gross DR 2000b Effect of estrogen on global myocardial ischemia reperfusion injury in female rats. American Journal of Physiology, Heart and Circulatory Physiology 279 H2766-H2775.
43. Zwart W, Griekspoor A, Rondaij M, Verwoerd D, Neefjes J & Michalides R 2007 Classification of anti-estrogens according to intramolecular FRET effects on phospho-mutants ofestrogen receptor alpha. Molecular Cancer Therapeutics 6 1526-1533.
44. Zweier JL, Kuppusamy P, Williams R, Rayburn BK, Smith D, Weisfeldt ML & Flaherty JT 1989 Measurement and characterization of postischemic free radical generation in the isolated perfused heart. Journal of Biological Chemistry 264 18890-18895.